INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,470,678 | -2.1% | 46,511 | +26.2% | 0.01% | 0.0% |
| Q2 2023 | $1,502,865 | +125347.8% | 36,853 | +14.6% | 0.01% | +20.0% |
| Q1 2023 | $1,198 | +47.0% | 32,149 | +37.6% | 0.01% | +25.0% |
| Q4 2022 | $815 | -100.0% | 23,361 | -23.4% | 0.00% | -55.6% |
| Q3 2022 | $1,705,000 | +46.2% | 30,490 | +35.3% | 0.01% | +50.0% |
| Q2 2022 | $1,166,000 | -26.7% | 22,532 | +2.9% | 0.01% | -25.0% |
| Q1 2022 | $1,590,000 | -10.8% | 21,890 | +45.2% | 0.01% | 0.0% |
| Q4 2021 | $1,782,000 | +289.9% | 15,076 | +342.5% | 0.01% | +300.0% |
| Q3 2021 | $457,000 | +319.3% | 3,407 | +401.0% | 0.00% | +100.0% |
| Q2 2021 | $109,000 | +118.0% | 680 | +8.6% | 0.00% | – |
| Q1 2021 | $50,000 | +150.0% | 626 | +67.8% | 0.00% | – |
| Q4 2020 | $20,000 | +233.3% | 373 | +14.8% | 0.00% | – |
| Q3 2020 | $6,000 | – | 325 | +4542.9% | 0.00% | – |
| Q4 2019 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |